273
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Long-Term Outcome Measures of Repeated Non-Animal Stabilized Hyaluronic Acid (Durolane) Injections in Osteoarthritis: A 6-Year Cohort Study with 623 Consecutive Patients

, & ORCID Icon
Pages 285-292 | Published online: 18 Sep 2021

References

  • Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results. Available from: http://ghdx.healthdata.org/gbd-results-tool. Accessed July 10 2021.
  • Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84(3):351–358. doi:10.2105/AJPH.84.3.351
  • Losina E, Paltiel AD, Weinstein AM, et al. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res. 2015;67(2):203–215. doi:10.1002/acr.22412
  • Wen DY. Intra-articular hyaluronic acid injections for knee osteoarthritis. Am Fam Physician. 2000;62(3):565–570, 572.
  • Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E. Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee. Am J Sports Med. 2016;44(8):2158–2165. doi:10.1177/0363546515609599
  • Agerup B, Berg P, Akermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs. 2005;19(1):23–30. doi:10.2165/00063030-200519010-00003
  • Lindqvist U, Tolmachev V, Kairemo K, Aström G, Jonsson E, Lundqvist H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet. 2002;41(8):603–613. doi:10.2165/00003088-200241080-00004
  • Edsman K, Hjelm R, Lärkner H, et al. Intra-articular duration of Durolane™ after single injection into the rabbit knee. Cartilage. 2011;2(4):384–388. doi:10.1177/1947603511400184
  • Leighton R, Fitzpatrick J, Smith H, Crandall D, Flannery C, Conrozier T. Systematic clinical evidence review of NASHA (Durolane hyaluronic acid) for the treatment of knee osteoarthritis. Open Rheumatol J. 2018;10:43–54.
  • Leighton R, Akermark C, Therrien R, et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthr Cartil. 2014;22(1):17–25. doi:10.1016/j.joca.2013.10.009
  • Altman R, Hackel J, Niazi F, Shaw P, Nicholls M. Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: a systematic review. Semin Arthritis Rheum. 2018;48(2):168–175. doi:10.1016/j.semarthrit.2018.01.009
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X
  • Bowman EN, Hallock JD, Throckmorton TW, Azar FM. Hyaluronic acid injections for osteoarthritis of the knee: predictors of successful treatment. Int Orthop. 2018;42(4):733–740. doi:10.1007/s00264-017-3731-8
  • Wilder E, Flanagan R, Strauss E, Samuels J. BMI, age, radiographic severity and ultrasound guidance impact the response to hyaluronic acid injections in knee osteoarthritis. Osteoarthr Cartil. 2015;23:A405–A406. doi:10.1016/j.joca.2015.02.751
  • Henrotin Y, Raman R, Richette P, et al. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Semin Arthritis Rheum. 2015;45(2):140–149. doi:10.1016/j.semarthrit.2015.04.011
  • Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578–1589. doi:10.1016/j.joca.2019.06.011
  • Altman R, Lim S, Steen RG, Dasa V. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large U.S. Health Claims Database. PLoS One. 2015;10(12):e0145776. doi:10.1371/journal.pone.0145776